Alaunos Therapeutics (TCRT) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $921000.0.
- Alaunos Therapeutics' Total Liabilities rose 1150.12% to $921000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $921000.0, marking a year-over-year increase of 1150.12%. This contributed to the annual value of $692000.0 for FY2024, which is 6462.17% down from last year.
- Latest data reveals that Alaunos Therapeutics reported Total Liabilities of $921000.0 as of Q3 2025, which was up 1150.12% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Alaunos Therapeutics' Total Liabilities ranged from a high of $45.1 million in Q3 2021 and a low of $692000.0 during Q4 2024
- Moreover, its 5-year median value for Total Liabilities was $6.3 million (2023), whereas its average is $15.5 million.
- As far as peak fluctuations go, Alaunos Therapeutics' Total Liabilities skyrocketed by 11479.31% in 2021, and later crashed by 9351.77% in 2024.
- Alaunos Therapeutics' Total Liabilities (Quarter) stood at $36.8 million in 2021, then dropped by 28.33% to $26.4 million in 2022, then plummeted by 92.59% to $2.0 million in 2023, then tumbled by 64.62% to $692000.0 in 2024, then soared by 33.09% to $921000.0 in 2025.
- Its last three reported values are $921000.0 in Q3 2025, $1.1 million for Q2 2025, and $1.1 million during Q1 2025.